| Accession Number: | 0000921895-21-002200 |
| Date: | 2021-08-23 |
| Issuer: | HARVARD BIOSCIENCE INC (HBIO) |
| Original Submission Date: |
GREEN JAMES W
C/O HARVARD BIOSCIENCE, INC.
84 OCTOBER HILL ROAD
HOLLISTON, MA 01746
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2021-08-23 | S | 48,175 | d | $8.02 | 2,091,725 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|
| ID | footnote |
|---|---|
| f1 | this transaction was executed in multiple trades at prices ranging from $7.97 to $8.10, inclusive. the price reported above reflects the weighted average purchase price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| f2 | includes (a) 218,141 remaining restricted stock units that will vest on june 11, 2022 and 2023, (b) 194,698 restricted stock units that will vest in three equal installments on december 31, 2021, 2022 and 2023, (c) 163,606 remaining restricted stock units that will vest on december 31, 2021, 2022 and 2023, (d) 209,180 remaining restricted stock units that will vest on january 1, 2022 and 2023, (e) 605,035 restricted stock units with performance based vesting conditions tied to relative total shareholder return, and (f) 701,065 shares of common stock beneficially owned by the reporting person. |
